Severe community-acquired Enterobacter pneumonia: A plea for greater awareness of the concept of health-care-associated pneumonia

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Boyer, Alexandre ^a,b,c   Amadeo, Brice ^b,c   Vargas, Frédéric ^a   Yu, Ma ^a   Maurice Tison, Sylvie ^b   Dubois, Véronique ^a   Bébéar, Cécile ^a   Rogues, Anne M ^b,c   Gruson, Didier ^a  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM   (France)

Author keywords

Enterobacter aerogenes; Enterobacter cloacae; Gram negative pneumonia; Health care associated pneumonia community acquired pneumonia

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AWARENESS; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROBACTER; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTOSIS; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PNEUMONIA; PRACTICE GUIDELINE; RADIOGRAPHY; UNIVARIATE ANALYSIS; AGED; BACTERIAL PNEUMONIA; COMMUNICABLE DISEASE; CROSS INFECTION; GENETICS; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AWARENESS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENTEROBACTER; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 79955770426     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-120     Document Type: Article

References (25)

1. Karnad A, Alvarez S, Berk SL. Pneumonia caused by Gram-negative bacilli. Am J Med 1985, 79:61-67.
2. Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzales J, Niedermann NS, Torres A. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002, 162:1849-1858.
3. Ruiz M, Ewig S, Marcos MN, Martinez JA, Arancibia F, Mensa J, Torres A. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999, 160:397-405.
4. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994, 18:501-515.
5. Rodriguez A, Mendia A, Sirvent JM, Barcenilla F, De la Torre-Prados MV, Sole-Violan J, Rello J, . for the CAPUCI study group Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 2007, 35:1493-1498. for the CAPUCI study group.
6. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and health-care-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
7. Comité technique des infections nosocomiales et des infections liées aux soins. , http://www.sante.gouv.fr/IMG/pdf/rapport_vcourte.pdf
8. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
9. Vincent JL, Moreno R, Takala J, Willatts S, De Meendonça A, Bruining H, . on behalf of the working group on sepsis related problems of the ESICM The SOFA (Sepsis Related Organ Failure Assessment) score to describe organ dysfunction/failure. Intens Care Med 1996, 22:707-710. on behalf of the working group on sepsis related problems of the ESICM.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference.
11. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health-care-associated pneumonia and community-acquired-pneumonia: a single-center experience. Antimicrob Agents Chemother 2007, 51:3568-3573.
12. Kollef MH, Napolitano LM, Solomkin JS, Wunderink RG, Bae IG, Fowler VG, Balk RA, Stevens DL, Rahal JJ, Shorr AF, Linden PK, Micek ST. Health care-associated infection (HAI): a critical appraisal of the emerging threat--Proceedings of the HAI summit. Clinical Infectious Diseases 2008, 47:S55-99.
13. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Resp Crit Care Med 1994, 149:818-824.
14. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988, 10:867-878.
15. Bouza E, De La Torre MG, Erice A, Loza E, Diaz-Borrego JM, Buzon L. Enterobacter bacteremia: an analysis of 50 episodes. Arch Intern Med 1985, 145:1024-1027.
16. Broughton WA, Kirkpatrick MB. Acute necrotizing pneumonia caused by Enterobacter cloacae. South Med J 1988, 81:1061-1062.
17. Unger JB, Rose HD, Unger GF. Gram-negative pneumonia. Radiology 1973, 107:283-291.
18. Kollef MH. Health care-associated pneumonia: perception versus reality. Clin Infect Dis 2009, 49:1875-1877.
19. Abrahamian FM, Deblieux PM, Emerman CL, Kollef MH, Kupersmith E, Leeper KV, Paterson DL, Shorr AF. Health-care-associated pneumonia: identification and initial management in the emergency department. Am J Emerg Med 2008, 26:1-11.
20. Seymann GB, Di Francisco L, Sharpe B, Rohde J, Fedullo P, Schneir A, Fee C, Chan KM, Fatehi P, Dam TT. The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia. Clin Infect Dis 2009, 49:1868-1874.
21. Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005, 56:52-59.
22. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R. Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in non hospitalized patients. Eur J Clin Microbiol Infect Dis 2004, 23:163-167.
23. Skippen I, Shemko M, Turton J, Kaufmann ME, Palmer C, Shetty N. Epidemiology of infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London. J Hosp Infect 2006, 64:115-123.
24. Arpin C, Dubois V, Maugein J, Jullin J, Dutilh B, Brochet JP, Larribet G, Fischer I, Quentin C. Clinical and molecular analysis of extended-spectrum β-lactamase producing Enterobacteriaceae in the community setting. J Clin Microbiol 2005, 43:5048-5054.
25. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.